HALO
Halozyme Therapeutics Inc
109.80$
-0.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 28.7% | 20.5% | 25.5% | 23.1% | 13.1% | 4.0% | 9.9% | 2.4% | 2.4% | 9.3% | 8.2% | 4.8% | 48.3% | 31.1% | 22.8% | 10.4% | 8.5% | 21.6% | 20.5% | 16.9% | 16.0% | 21.2% | 13.6% | 22.3% | 22.6% | 23.2% | 21.7% | 22.7% | 25.4% | 22.7% | 23.5% | 24.8% | 17.0% | 14.1% | 25.0% | 19.7% | 15.6% | 17.4% | 21.0% | 16.5% | 17.6% | |
| 71.3% | 79.5% | 74.5% | 76.9% | 86.9% | 96.0% | 90.1% | 97.6% | 97.6% | 90.7% | 91.8% | 95.2% | 51.7% | 68.9% | 77.2% | 89.6% | 91.5% | 78.4% | 79.5% | 83.1% | 84.0% | 78.8% | 86.4% | 77.7% | 77.4% | 76.8% | 78.3% | 77.3% | 74.6% | 77.3% | 76.5% | 75.2% | 83.0% | 85.9% | 75.0% | 80.3% | 84.4% | 82.6% | 79.0% | 83.5% | 82.4% | |
| 106.3% | 106.0% | 124.9% | 113.6% | 53.3% | 21.8% | 123.0% | 113.9% | 139.1% | 60.8% | 55.0% | 86.6% | 65.9% | 84.1% | 40.1% | 16.2% | 11.9% | 6.1% | 10.1% | 5.9% | 7.3% | 9.9% | 10.1% | 10.2% | 8.0% | 12.4% | 11.1% | 8.9% | 8.0% | 9.3% | 9.8% | 9.1% | 6.4% | 6.9% | 5.6% | 5.4% | 4.9% | 7.1% | 6.8% | 5.8% | 6.2% | |
| 36.4% | 31.3% | 42.7% | 38.8% | 20.9% | 7.8% | 43.9% | 40.8% | 58.2% | 29.9% | 31.6% | 44.3% | 38.9% | 44.6% | 49.8% | 19.9% | 17.9% | 10.4% | 12.4% | 9.0% | 11.4% | 13.5% | 11.8% | 37.7% | 16.5% | 20.8% | 23.0% | 17.6% | 16.3% | 16.3% | 17.9% | 15.4% | 14.2% | 14.2% | 16.0% | 12.8% | 13.0% | 17.1% | 15.4% | 11.8% | 14.3% | |
| 142.7% | 137.4% | 167.6% | 152.4% | 74.3% | 29.6% | 166.9% | 154.6% | 197.2% | 90.8% | 86.6% | 130.9% | 104.8% | 128.6% | 89.9% | 36.1% | 29.8% | 14.6% | 22.5% | 14.9% | 18.7% | 23.4% | 21.9% | 55.4% | 37.5% | 35.7% | 45.1% | 34.6% | 33.8% | 33.3% | 27.7% | 24.5% | 26.7% | 27.0% | 21.6% | 18.2% | 22.9% | 29.3% | 30.0% | 23.7% | 26.5% | |
| -71.4% | -57.9% | -93.1% | -75.5% | 12.7% | 66.4% | -76.8% | -57.0% | -99.7% | -0.1% | 5.2% | -35.7% | -53.1% | -59.7% | -12.7% | 53.5% | 61.7% | 63.8% | 57.0% | 68.2% | 65.3% | 55.4% | 64.5% | 22.4% | 39.9% | 41.1% | 33.2% | 42.7% | 40.9% | 43.9% | 48.8% | 50.7% | 56.3% | 58.9% | 53.4% | 62.2% | 61.5% | 53.3% | 49.0% | 59.8% | 55.9% | |
| 16.5% | 14.4% | 18.4% | 16.4% | 8.7% | 2.9% | 16.9% | 13.6% | 16.8% | 6.2% | 5.6% | 6.7% | 4.5% | 7.0% | 21.1% | 9.1% | 7.6% | 4.1% | 2.2% | 1.3% | 1.5% | 2.0% | 1.5% | 2.0% | 3.6% | 2.5% | 2.8% | 2.0% | 2.1% | 2.3% | 2.3% | 2.0% | 1.6% | 1.5% | 1.7% | 1.3% | 1.2% | 1.1% | 1.5% | 1.2% | 1.2% | |
| -86.8% | -71.3% | -110.5% | -90.6% | 5.2% | 64.1% | -88.3% | -64.9% | -109.0% | -3.0% | 3.2% | -37.3% | -54.1% | -64.2% | -24.0% | 46.9% | 55.5% | 60.2% | 31.5% | 67.1% | 64.0% | 53.7% | 63.4% | 19.7% | 35.3% | 39.0% | 32.2% | 42.1% | 47.1% | 44.0% | 49.0% | 50.9% | 56.9% | 59.8% | 54.3% | 62.9% | 61.8% | -22.3% | 47.9% | 59.2% | 35.1% | |
| 4.0% | -1.1% | 0.7% | 0.5% | 0.9% | -1.2% | 0.6% | 0.1% | 16.8% | 0.5% | 0.0% | 0.0% | 0.0% | -0.1% | 0.0% | 0.1% | 0.1% | 0.1% | 0.2% | 0.0% | -123.0% | -11.7% | 12.2% | 4.8% | 5.8% | 7.2% | 7.8% | 8.3% | 9.2% | 6.9% | 9.8% | 10.6% | 9.7% | 13.8% | 9.7% | 12.2% | 12.3% | 9.0% | 8.0% | 11.4% | 10.2% | |
| -90.9% | -70.2% | -111.3% | -91.1% | 4.3% | 65.4% | -89.0% | -65.0% | -109.0% | -3.5% | 3.2% | -37.4% | -54.1% | -64.1% | -24.1% | 46.8% | 55.4% | 60.1% | 31.3% | 67.0% | 187.0% | 65.5% | 51.3% | 14.9% | 29.5% | 31.8% | 24.4% | 33.8% | 37.9% | 37.1% | 39.2% | 40.3% | 47.2% | 46.0% | 44.6% | 50.7% | 49.5% | -31.3% | 39.8% | 47.8% | 24.9% | |
| -68.3% | -55.3% | -90.1% | -72.4% | 13.5% | 66.7% | -69.6% | -49.7% | -89.9% | 0.9% | 6.9% | -28.1% | -47.4% | -55.3% | 0.4% | 57.4% | 64.4% | 65.0% | 34.6% | 68.9% | 66.1% | 56.5% | 65.6% | 29.9% | 52.8% | 45.4% | 47.6% | 53.5% | 59.9% | 55.2% | 61.6% | 61.6% | 65.5% | 68.2% | 63.7% | 70.5% | 68.8% | -15.3% | 58.3% | 67.5% | 43.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.